Home » Cellular therapies increasingly present in Europe

Cellular therapies increasingly present in Europe

by admin

The location is Leiden, Holland, in the expanding ‘life sciences’ region near Amsterdam. This is where Bristol Myers Squibb decided to build a new cell therapy manufacturing site, thereby strengthening its commitment to patients with aggressive hematological cancers. The investment enhances global manufacturing capacity and will be the company’s fifth state-of-the-art cell therapy manufacturing center and first in Europe, adding to major manufacturing partnerships globally.

“The key element of BMS’s commitment to cell therapies is the continued investment in advanced manufacturing capabilities, the expansion of our global network and the ability to treat patients, reducing delivery times and optimizing costs,” says Ann. Lee, Ph.D., Senior Vice President, Cell Therapy Development & Operations, Bristol Myers Squibb. “We continue to grow our presence in Europe and particularly in the Netherlands, which offers an innovative hub for life sciences and industrial talent worldwide. We look forward to recruiting hundreds of talented individuals over the next few years who will be able to join our global team and participate in our journey in cell therapy. ”

The European headquarters will be commercially focused on manufacturing multi-product cell therapies and increasing production capacity. It will leverage innovative technologies, the latest manufacturing equipment and advanced digital systems to ensure patient access to cell therapies. The design and development of the site is underway and construction is expected to begin later this year.

.

See also  The 7 amazing benefits of cashews

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy